Previous studies have also indicated that Sp1 can coregulate its target genes together with the ER [24, 33, 34]; therefore, in females with late-stage lung cancer, Sp1 may collaborate with the ER to regulate gene expression and thereby affect the survival rate. The gene discussed is SP1; the disease is lung carcinoma.